• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Issuer Direct Corporation - Product Image

Issuer Direct Corporation

  • ID: 620914
  • February 2015
  • 56 Pages
  • Wright Investors Service

A textual analysis of the financial results for Issuer Direct Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Issuer Direct Corporation. There is a textual review of the financial results of Issuer Direct Corporation versus Roomlinx, Inc., UBL Interactive Incoporated and First Choice Healthcare Solutions Inc. The comparative analysis of these companies compares READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

United States

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Microsoft Corporation - Product Thumbnail Image

    Microsoft Corporation

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • Talisman Energy Inc - Product Thumbnail Image

    Talisman Energy Inc

    • Language: English
    • 55 Pages
    • Published: February 2015
    FROM
  • Shanghai Electric Group Company Ltd - Product Thumbnail Image

    Shanghai Electric Group Company Ltd

    • Language: English
    • 56 Pages
    • Published: January 2015
  • PetroChina Co Ltd - Product Thumbnail Image

    PetroChina Co Ltd

    • Language: English
    • 56 Pages
    • Published: February 2015
    FROM
  • Telefonica SA - Product Thumbnail Image

    Telefonica SA

    • Language: English
    • 57 Pages
    • Published: February 2015
    FROM
  • First Choice Healthcare Solutions Inc - Product Thumbnail Image

    First Choice Healthcare Solutions Inc

    • Language: English
    • 55 Pages
    • Published: February 2015
    FROM
  • Stealth Ventures Incoporated - Product Thumbnail Image

    Stealth Ventures Incoporated

    • Language: English
    • 55 Pages
    • Published: February 2015
    FROM
  • Lightbridge Corporation - Product Thumbnail Image

    Lightbridge Corporation

    • Language: English
    • 56 Pages
    • Published: December 2014
  • Roomlinx, Inc. - Product Thumbnail Image

    Roomlinx, Inc.

    • Language: English
    • 56 Pages
    • Published: December 2014
  • UBL Interactive Incoporated - Product Thumbnail Image

    UBL Interactive Incoporated

    • Language: English
    • 52 Pages
    • Published: January 2015

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.